Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  zoledronic acid
Find trials that include:  Any drugs shown
Results 1-5 of 5 for your search:
Start Over
Ixazomib Citrate, Lenalidomide, Dexamethasone, and Zoledronic Acid or Zoledronic Acid Alone after Radiation Therapy in Treating Patients with Solitary Plasmacytoma of Bone
Status: Active
Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: A061402, NCI-2015-00323, NCT02516423
Study of Nifurtimox to Treat Refractory or Relapsed Neuroblastoma or Medulloblastoma
Status: Active
Phase: Phase II
Type: Treatment
Age: 21 and under
Trial IDs: V0706, NCI-2014-00478, NCT00601003
Genetically Modified Donor Stem Cell Transplant Followed by Zoledronic Acid in Treating Younger Patients with Relapsed/Refractory Hematologic Malignancies or High Risk Solid Tumors
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 7 months to 21 years
Trial IDs: UW13090, NCI-2015-01163, NCT02508038
Genetics in Predicting Risk of Bisphosphonate-Related Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid
Status: Not yet active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Age: Over 18
Trial IDs: 0S-13-3, NCI-2014-00207, NCT02069340
Zoledronic Acid in Preventing Bone Loss in Patients Undergoing Stem Cell Transplant
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Prevention
Age: 19 and over
Trial IDs: VAR0122-BMT290, NCI-2015-00923, NCT02451462
Start Over